Titan Pharmaceuticals Statistics
Total Valuation
TTNP has a market cap or net worth of $3.25 million. The enterprise value is -$754,046.
Important Dates
The next estimated earnings date is Friday, November 29, 2024, after market close.
| Earnings Date | Nov 29, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TTNP has 914,234 shares outstanding. The number of shares has increased by 10.30% in one year.
| Current Share Class | 914,234 |
| Shares Outstanding | 914,234 |
| Shares Change (YoY) | +10.30% |
| Shares Change (QoQ) | +7.15% |
| Owned by Insiders (%) | 23.43% |
| Owned by Institutions (%) | 2.82% |
| Float | 700,056 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.84 |
| P/TBV Ratio | 0.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.22
| Current Ratio | 12.22 |
| Quick Ratio | 11.60 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -309.96 |
Financial Efficiency
Return on equity (ROE) is -368.99% and return on invested capital (ROIC) is -288.58%.
| Return on Equity (ROE) | -368.99% |
| Return on Assets (ROA) | -172.63% |
| Return on Capital (ROIC) | -288.58% |
| Revenue Per Employee | $750 |
| Profits Per Employee | -$1.37M |
| Employee Count | 4 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.32% in the last 52 weeks. The beta is 1.12, so TTNP's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | -46.32% |
| 50-Day Moving Average | 4.68 |
| 200-Day Moving Average | 6.12 |
| Relative Strength Index (RSI) | 31.86 |
| Average Volume (20 Days) | 8,108 |
Short Selling Information
The latest short interest is 10,100, so 1.10% of the outstanding shares have been sold short.
| Short Interest | 10,100 |
| Short Previous Month | 16,968 |
| Short % of Shares Out | 1.10% |
| Short % of Float | 1.44% |
| Short Ratio (days to cover) | 1.04 |
Income Statement
In the last 12 months, TTNP had revenue of $3,000 and -$5.46 million in losses. Loss per share was -$6.67.
| Revenue | 3,000 |
| Gross Profit | -907,000 |
| Operating Income | -7.13M |
| Pretax Income | -4.95M |
| Net Income | -5.46M |
| EBITDA | -7.09M |
| EBIT | -7.13M |
| Loss Per Share | -$6.67 |
Full Income StatementBalance Sheet
| Cash & Cash Equivalents | 4.09M |
| Total Debt | n/a |
| Net Cash | 4.09M |
| Net Cash Per Share | $4.48 |
| Equity (Book Value) | 3.99M |
| Book Value Per Share | 4.37 |
| Working Capital | 3.99M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$6.76 million and capital expenditures -$2,000, giving a free cash flow of -$6.76 million.
| Operating Cash Flow | -6.76M |
| Capital Expenditures | -2,000 |
| Free Cash Flow | -6.76M |
| FCF Per Share | -$7.40 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -237,633.33% |
| Pretax Margin | -182,033.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -6,937.93% |